Cascio v. Johnson & Johnson

CourtDistrict Court, N.D. Georgia
DecidedFebruary 20, 2024
Docket1:23-cv-03127
StatusUnknown

This text of Cascio v. Johnson & Johnson (Cascio v. Johnson & Johnson) is published on Counsel Stack Legal Research, covering District Court, N.D. Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cascio v. Johnson & Johnson, (N.D. Ga. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF GEORGIA ATLANTA DIVISION

DEBRA CASCIO, et al.,

Plaintiffs,

v. CIVIL ACTION FILE

NO. 1:23-CV-3127-TWT

JOHNSON & JOHNSON, et al.,

Defendants.

OPINION AND ORDER This is a product liability case. It is before the Court on the Defendants’1 Motion to Dismiss [Doc. 18] and the Plaintiffs’2 Motion to Supplement the Response Brief [Doc. 26]. For the reasons explained below, the Defendants’ Motion to Dismiss [Doc. 18] is GRANTED and the Plaintiffs’ Motion to Supplement [Doc. 26] is GRANTED. I. Background3 This case involves sunscreen that allegedly caused the Plaintiff Debra Cascio to develop acute lymphoblastic leukemia (“ALL”). The Defendants are foreign corporations who were incorporated and have their principal place of

1 The Defendants in this case are Johnson & Johnson and Johnson & Johnson Consumer, Inc. (Compl. ¶¶ 5-6). The Court will collectively refer to them as “Defendants.” 2 The Plaintiffs in this case are Debra and Dan Cascio. (Compl. ¶¶ 3-4). The Court will collectively refer to them as “Plaintiffs.” 3 The Court accepts the facts as alleged in the Complaint as true for purposes of the present Motion to Dismiss. , 941 F.3d 1116, 1122 (11th Cir. 2019). business in New Jersey. (Compl. ¶¶ 5-6). At all relevant times, the Defendants were in the business of designing, manufacturing, testing, training, marketing, promoting, packaging, labeling, and selling sunscreen products. ( ¶ 8). The

Plaintiffs are individuals domiciled in Georgia. ( ¶¶ 3-4). Plaintiff Debra Cascio began using Neutrogena Beach Defense sunscreens in or around 2016. (Compl. ¶ 32). She used the sunscreens daily and applied it to her neck, shoulders, arms, hands, legs, feet, and face. ( ). She regularly applied the sunscreen to her body 3-4 times daily but would decrease her usage on days when it was raining. ( ). The Defendants recalled

all lots of five Neutrogena and Aveeno aerosol sunscreen product lines— including the Beach Defense line—in response to a citizen petition to the FDA by Valisure, LLC. ( ¶¶ 14, 16; Maguire Decl., Ex. B4). Valisure “tested and detected high levels of benzene, a known human carcinogen, in several brands and batches of sunscreen,” including some made by the Defendants. ( ¶ 17).

4 The Plaintiffs did not attach the recall notice to its Complaint, even though they listed it as an exhibit. (Compl. ¶ 14). The Defendants have attached the recall notice to its Motion to Dismiss. (Defs.’ Br. in Supp. of Mot to Dismiss, at 3 n. 2; Maguire Decl., Ex. B.). “[W]here the plaintiff refers to certain documents in the complaint and those documents are central to the plaintiff's claim, then the Court may consider the documents part of the pleadings for purposes of Rule 12(b)(6) dismissal, and the defendant's attaching such documents to the motion to dismiss will not require conversion of the motion into a motion for summary judgment.” , 116 F.3d 1364, 1369 (11th Cir. 1997) (citation omitted). The Court finds this is the case with respect to the recall notice as well as the Valisure Petition. 2 Plaintiff Debra Cascio used sunscreen products until she received an email from Costco on or about July 15, 2021, that informed her of the Defendants’ recall. ( ¶¶ 34). In July 2021, she was diagnosed with ALL, a disease that is

rarely seen in adults without benzene exposure. ( ¶¶ 35-36). Based on these facts, the Plaintiffs have filed suit alleging product liability, negligence, misrepresentation, breach of warranty, and loss of consortium claims. The Defendants now move to dismiss the Complaint. II. Legal Standard A complaint should be dismissed under Rule 12(b)(6) only where it

appears that the facts alleged fail to state a “plausible” claim for relief. , 556 U.S. 662, 678 (2009); Fed. R. Civ. P. 12(b)(6). A complaint may survive a motion to dismiss for failure to state a claim, however, even if it is “improbable” that a plaintiff would be able to prove those facts; even if the possibility of recovery is extremely “remote and unlikely.” , 550 U.S. 544, 556 (2007). In ruling on a motion to dismiss, the court must accept the facts pleaded in the complaint as true and construe them in

the light most favorable to the plaintiff. , 711 F.2d 989, 994-95 (11th Cir. 1983); , 40 F.3d 247, 251 (7th Cir. 1994) (noting that at the pleading stage, the plaintiff “receives the benefit of imagination”). Generally, notice pleading is all that is

3 required for a valid complaint. , 753 F.2d 974, 975 (11th Cir. 1985). Under notice pleading, the plaintiff need only give the defendant fair notice of the plaintiff’s claim and the grounds upon

which it rests. , 551 U.S. 89, 93 (2007) (citing , 550 U.S. at 555). III. Discussion The Defendants argue that the Complaint should be dismissed because the Plaintiffs fail to sufficiently allege product identification, causation, and misrepresentation. Since the loss of consortium claim and the request for

punitive damages are derivative, the Defendants assert that they should be dismissed along with the underlying claims. The Court agrees that the Plaintiffs have failed to allege causation and thus dismisses all claims. In the Complaint, the Plaintiffs allege that Debra Cascio used “the recalled Neutrogena Beach Defense SPF 30, 50, 60, or 70.” (Compl. ¶ 32). The Defendants contend that “[b]y referring to the products only by the product name, without any other identifying information, Plaintiffs have failed to

sufficiently allege product identification to plead their claims.” (Defs.’ Br. in Supp. of Mot. to Dismiss, at 6). Moreover, “the Complaint fails to plausibly plead that all of JJCI’s sunscreen products have consistently contained benzene, or that the benzene content in any sunscreen product Debra Cascio allegedly used caused her to be exposed to sufficient concentrations of benzene

4 to have caused her injury.” ( at 15). The Court agrees with the Defendants. To demonstrate that the sunscreen she used contained benzene, Plaintiff Debra Cascio relies on a voluntary recall notice issued by the

Defendants as well as a citizen petition submitted by Valisure. (Compl. ¶¶ 14, 16-18). For starters, a recall of a product is not evidence of a defect. , , 2022 WL 833608, at *9 (D.N.J. March 21, 2022) (noting that “[a] recall will often be overinclusive” and that “the mere existence of a recall does not prove that any individual's vehicle actually contained a nonconformity.”); , 2022 WL

2542291, at *9 (E.D. Va. July 7, 2022) (“[A] general recall is not evidence that any of the Plaintiffs’ vehicles possessed some defect.” (collecting cases)). Thus, the Defendants’ recall notice alone cannot support a plausible inference that the sunscreen Plaintiff Debra Cascio used contained benzene. , 350 F. Supp. 2d 1036, 1045 (N.D. Ga.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Cascio v. Johnson & Johnson, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cascio-v-johnson-johnson-gand-2024.